439 related articles for article (PubMed ID: 18786563)
1. The myocardial JAK/STAT pathway: from protection to failure.
Boengler K; Hilfiker-Kleiner D; Drexler H; Heusch G; Schulz R
Pharmacol Ther; 2008 Nov; 120(2):172-85. PubMed ID: 18786563
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion.
Heusch G; Musiolik J; Gedik N; Skyschally A
Circ Res; 2011 Nov; 109(11):1302-8. PubMed ID: 21980124
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
4. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
[TBL] [Abstract][Full Text] [Related]
5. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
6. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
Hausenloy DJ; Tsang A; Yellon DM
Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium.
Yang XP; Irani K; Mattagajasingh S; Dipaula A; Khanday F; Ozaki M; Fox-Talbot K; Baldwin WM; Becker LC
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1395-400. PubMed ID: 15860735
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice.
Boengler K; Buechert A; Heinen Y; Roeskes C; Hilfiker-Kleiner D; Heusch G; Schulz R
Circ Res; 2008 Jan; 102(1):131-5. PubMed ID: 17967780
[TBL] [Abstract][Full Text] [Related]
9. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition.
Drenger B; Ostrovsky IA; Barak M; Nechemia-Arbely Y; Ziv E; Axelrod JH
Anesthesiology; 2011 Jun; 114(6):1364-72. PubMed ID: 21368653
[TBL] [Abstract][Full Text] [Related]
10. NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.
Ottani A; Giuliani D; Neri L; Calevro A; Canalini F; Vandini E; Cainazzo MM; Ruberto IA; Barbieri A; Rossi R; Guarini S
Eur J Pharmacol; 2015 Dec; 769():22-32. PubMed ID: 26477637
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Liu YP; Tan YN; Wang ZL; Zeng L; Lu ZX; Li LL; Luo W; Tang M; Cao Y
Int J Mol Med; 2008 Feb; 21(2):153-62. PubMed ID: 18204781
[TBL] [Abstract][Full Text] [Related]
12. Signaling networks regulating cardiac myocyte survival and death.
Wagner M; Siddiqui MA
Curr Opin Investig Drugs; 2009 Sep; 10(9):928-37. PubMed ID: 19705335
[TBL] [Abstract][Full Text] [Related]
13. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart.
Oshima Y; Fujio Y; Nakanishi T; Itoh N; Yamamoto Y; Negoro S; Tanaka K; Kishimoto T; Kawase I; Azuma J
Cardiovasc Res; 2005 Feb; 65(2):428-35. PubMed ID: 15639482
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury.
Hilfiker-Kleiner D; Hilfiker A; Fuchs M; Kaminski K; Schaefer A; Schieffer B; Hillmer A; Schmiedl A; Ding Z; Podewski E; Podewski E; Poli V; Schneider MD; Schulz R; Park JK; Wollert KC; Drexler H
Circ Res; 2004 Jul; 95(2):187-95. PubMed ID: 15192020
[TBL] [Abstract][Full Text] [Related]
15. Role of the JAK-STAT pathway in myocardial injury.
Barry SP; Townsend PA; Latchman DS; Stephanou A
Trends Mol Med; 2007 Feb; 13(2):82-9. PubMed ID: 17194625
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning and postconditioning: united at reperfusion.
Hausenloy DJ; Yellon DM
Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
[TBL] [Abstract][Full Text] [Related]
17. Emulsified isoflurane induces postconditioning against myocardial infarction via JAK-STAT pathway.
Yan L; Jiang X; Tai W; Shi E
J Surg Res; 2012 Dec; 178(2):578-85. PubMed ID: 22749532
[TBL] [Abstract][Full Text] [Related]
18. JAK-STAT signaling circuits in myocarditis and dilated cardiomyopathy.
Ruppert V; Meyer T
Herz; 2007 Sep; 32(6):474-81. PubMed ID: 17882372
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
20. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Lecour S
J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
